Angiogenesis-Targeted 68 Ga-DOTA-RGD 2 PET/CT Imaging: a Potential Theranostic Application in the Case of Chondrosarcoma

We present a case of a 53-year-old man with grade II chondrosarcoma of the left femur showing only mild avidity on18F-FDG PET/CT but showing moderate to intense tracer avidity on68Ga-DOTA-RGD2 PET/CT. This may enable the use of angiogenesis-targeted positron and beta-emitting radiopharmaceuticals as a potentially new theranostic alternative treatment in cases of refractory metastatic chondrosarcoma.
Source: Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research